Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone
- 31 March 1997
- journal article
- case report
- Published by Elsevier in Immunobiology
- Vol. 196 (5) , 513-521
- https://doi.org/10.1016/s0171-2985(97)80068-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HIV and human complement: mechanisms of interaction and biological implicationImmunology Today, 1993
- Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassayClinical and Experimental Immunology, 1991
- CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.The Journal of Experimental Medicine, 1989
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- Human Serum SicknessMedicine, 1988
- Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.Journal of Clinical Investigation, 1987
- Serum sickness and haematopoietic recovery with antithymocyte globulin in bone marrow failure patientsBritish Journal of Haematology, 1986
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Deficiency of the Complement Regulatory Protein, Decay-Accelerating Factor, on Membranes of Granulocytes, Monocytes, and Platelets in Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine, 1985
- Aplastic AnemiaNew England Journal of Medicine, 1982